(For more resources, please see our page on molnupiravir.) According to Brook Baker, these are the countries included in the Merck voluntary license to generic suppliers Afghanistan, Algeria, Angola, Bangladesh, Belize, Benin, Bhutan, Bolivia, Botswana, Burkina Faso, Burundi, Cambodia, Cameroon,… Continue Reading
(For more resources, please see our page on molnupiravir.) KEI has built a dataset of patents related to molnupiravir based upon a study by Imran et al (2021), the Medicines Patent Pool (MPP) MedsPal database, and our own searches. Our… Continue Reading
On Wednesday, 13 October 2021, Indonesia delivered the following statement at the TRIPS Council discussions on the TRIPS waiver. PROPOSAL FOR A WAIVER FROM CERTAIN PROVISIONS OF THE TRIPS AGREEMENT FOR THE PREVENTION, CONTAINMENT AND TREATMENT OF COVID-19 Thank you,… Continue Reading
October 15, 2021 James Love In the past few days, two documents have been leaked regarding the European Union (EU)’s positions at the World Trade Organization (WTO), in negotiations over which rules if any at the WTO should be waived… Continue Reading
(Update: On November 4, 2021, the NIH provided a response to our comments on the license.) On October 12, 2021, Knowledge Ecology International (KEI) submitted comments to the National Institutes of Health (NIH) regarding the ““Prospective Grant of an Exclusive… Continue Reading
This is the statement the United States of America delivered on behalf of the US government at the WIPO General Assembly, on the work program for the Standing Committee on Copyright and Related Rights (SCCR) on Tuesday, 5 October 2021.… Continue Reading
On Tuesday, 5 October 2021, Knowledge Ecology International delivered the following statement on Agenda item 13, Report on the Standing Committee on Copyright and Related Rights (SCCR). Statement of Knowledge Ecology International – Agenda Item 13: Report on the Standing… Continue Reading
On Tuesday, 5 October 2021, Knowledge Ecology International delivered the following opening statement at the 2021 WIPO General Assembly. General Statement of Knowledge Ecology International – WIPO General Assembly 5 October 2021 The COVID pandemic illustrates flaws in the intellectual… Continue Reading
(For more resources, please see our page on molnupiravir.) Knowledge Ecology International (KEI) has obtained a copy of the $1.2 billion contract between the U.S. government and Merck to advance purchase 1,696,629 treatment courses of molnupiravir, an investigational COVID-19 drug… Continue Reading
(For more resources, please see our page on molnupiravir.) Molnupiravir, the oral pill that is showing promising results as a potential treatment for covid-19, was invented at Emory University with U.S. government funds. After more than six years of non-clinical… Continue Reading